AI in aesthetic clinics: what to automate and what to keep clinical

AI in aesthetic clinics is moving from conference agenda to everyday software. LOOK 2026 in Madrid has put the impact of AI on beauty businesses on the programme of its 18th Aesthetics Congress on 14 November. For a small UK clinic, though, the useful question is narrower than "should we use AI?" It is which tasks a tool can take over, and which decisions must stay with a qualified practitioner.

What the LOOK 2026 congress is, and what it isn't

The IFEMA press release of 21 September 2026 lists the impact of AI on the development of beauty businesses among the congress topics, with a closing session by an AI growth marketer on how AI can amplify a practitioner's personal brand. It is a Spanish beauty and aesthetics trade event, and the programme is framed around business growth rather than clinical practice or regulation.

That framing is common across the sector, and it is where the risk sits. When "AI" covers everything from a reminder text to a tool that suggests treatments, it becomes easy to treat all clinic tasks as if they carried the same level of risk. They don't.

What UK regulators say about AI in clinics

There is no aesthetics-specific AI rulebook in the UK yet, but the main regulators have set out their position.

• CQC. In its page on AI in health and social care, last updated 21 May 2026, CQC says AI can enhance but not replace human decision-making. It expects human oversight of AI outputs, clear accountability when something goes wrong, effective governance and a data protection impact assessment. CQC does not approve specific technologies; it assesses providers against the existing regulations, including safe care and good governance.
• GMC. Its guidance on AI and innovative technologies says doctors are responsible for the decisions they take when using AI, should work within their competence and should discuss the use of new technologies with patients.
• MHRA. Many software and AI products are regulated as medical devices. Whether a tool qualifies depends on its intended purpose as defined by the manufacturer, so a clinic should ask the vendor directly before using a tool that informs clinical decisions.

Nurse, pharmacist and dentist prescribers work under their own professional codes, which place accountability for clinical decisions with the registrant. Prescribing for non-surgical cosmetic medicines also requires a face-to-face consultation, which we cover in our article on consultations and cooling-off periods.

Where AI in aesthetic clinics earns its place

Most of the time a small clinic loses to software goes on the front desk: confirming and moving appointments, chasing forms, sending reminders and answering the same scheduling questions. None of it needs clinical judgement, and in a clinic of one to four people, every hour spent on it is an hour not spent with patients.

The grey zone: tools that support clinical work

The row marked “supports a clinical decision” is where most new AI features sit: tools that summarise a medical history, highlight answers in an intake form or draft treatment notes from a recording. They can save time, but their output becomes part of a clinical decision. Treat it as a draft that the practitioner checks, corrects and signs, and check the tool's regulatory status and data handling before patient information goes into it.

Collecting information before the consultation is administration. Deciding what that information means for a particular patient is clinical work. Keeping that line clear also keeps your audit trail clear: the record shows who made each decision and when.

Before you adopt an AI tool: a checklist

1. Name the task and its output. Write one sentence on what the tool does and whether the result is operational or clinical.
2. Ask the vendor about intended purpose. Ask whether the product is regulated as a medical device and what it is, and isn't, designed to do.
3. Check where patient data goes. Find out where data is stored and processed, whether it is used to train models, and complete a data protection impact assessment.
4. Keep a human sign-off. Anything that feeds into a clinical decision is reviewed and signed by the responsible practitioner before it is acted on.
5. Tell patients. Explain in your privacy information, and where relevant in the consultation, how AI tools are used in their care.
6. Write it into your policies. Add the tool to your governance documents, with an owner and a way to report and review problems.
7. Review it regularly. Check outputs against what actually happened, and stop using a tool that drifts from its purpose.

Frequently asked questions

Where MERIDIQ fits

MERIDIQ for aesthetic clinics is built around the line described above. The booking system, from £4 per user per month, handles the operational layer: online booking, automated SMS and email reminders, and questionnaires and consent forms attached to the booking flow. It also accepts bookings made through AI assistants, as described in our post on AI-agent friendly booking.

The clinical layer stays with the practitioner. In patient records, treatment notes and consent forms are linked to each appointment, signed digitally and covered by role-based access and audit logging, so the record shows who decided what. Policies for how your clinic uses AI tools can sit alongside your other governance documents in MERIDIQ's CQC compliance tools.

Sources

1. IFEMA MADRID, LOOK 2026 reveals details of the 18th Aesthetics Congress and a new edition of Beauty Night, 21 September 2026.
2. Care Quality Commission, Artificial intelligence in health and social care: CQC's role, expectations and plans, updated 21 May 2026.
3. General Medical Council, Artificial intelligence and innovative technologies, accessed 26 October 2026.
4. Medicines and Healthcare products Regulatory Agency, Software and artificial intelligence (AI) as a medical device, updated 3 February 2025.